The FDA will continue recommending annual COVID-19 vaccines for older adults and high-risk groups, but says more clinical data is needed for healthy adults and kids.

On May 20, U.S. Food and Drug Administration (FDA) officials announced that Covid-19 vaccines will no longer be available to ...

U.S. Social Security Administration Commissioner Frank Bisignano discusses the potential opportunities for fraud in the program, an incentive in the 'big, beautiful bill' for recipients and efforts to ...

Its new guidance would trade the clarity and reach of our current strategy for a confusing framework that simply doesn’t fit reality.

The best approach to covid-19 prevention may be to discuss it with your doctor, a leading vaccine expert told TribLive. But a drastic shift in national policy published Tuesday in the New England ...

O n May 20, the federal government announced a major shift in how it plans to review and recommend COVID-19 vaccines for Americans. Among the changes: when manufacturers want to u ...

FDA changes COVID-19 vaccine approval policy, major trials now required for widespread use. Higher risk individuals still ...

Healthy adults younger than 65 will no longer be eligible for COVID-19 shots starting in the fall, according to new federal ...

For groups younger than 65 or without specific chronic conditions, postmarketing trials will be needed to open access.

The FDA is getting rid of the Covid booster because . . . it's concerned about anti-vaxx sentiments. No, really.

In this week’s edition of InnovationRx, we look at the FDA's new rules on Covid-19 vaccines, Novartis’s acquisition strategy, ...

According to Makary and Prasad, the US’s adoption of a “one-size-fits-all” guidance for COVID-19 vaccination departs from ...